US-based biotech company Moderna is applying for the use of its Covid-19 vaccine for adolescents aged 12 to 17 in Switzerland, it said on Friday.
This content was published on
1 minute
Keystone-SDA/jc
Its vaccine is currently approved only for people aged 18 and over. So far, only Pfizer/BioNTech has been authorised by approvals authority Swissmedic to administer the vaccine to people over 12.
Swissmedic, the Swiss Agency for Therapeutic Products, said in a statement also on Friday that it is analysing the data submitted to it, including a large ongoing clinical trial being conducted on young people aged 12 and over.
The institute will decide on the Moderna application as soon as it has sufficient evidence of the safety, efficacy and quality of this vaccine against Covid-19 in this age group.
The vaccination rollout in Switzerland has accelerated, reaching between 60,000-90,000 jabs a day. Over 5.8 million Covid-19 doses were administered between late December and June 9. Over 25% of the population are fully vaccinated.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
What factors should be taken into account when inheriting Swiss citizenship abroad?
Should there be a limit to the passing on of Swiss citizenship? Or is the current practice too strict and it should still be possible to register after the age of 25?
US storm continues to sweep through Swiss stock market
This content was published on
The Swiss stock market continued to trade in the red mid-afternoon on Monday, following in the wake of the world's stock markets, which fell heavily as a result of the trade war launched by Donald Trump.
This content was published on
The referendum committee announced in Bern on Monday that it had collected more than 60,000 signatures against the e-ID project. The initials still need to be approved.
This content was published on
The number of offences committed by minors in canton Ticino, southern Switzerland, rose by over 20% in 2024 compared to the previous year.
Swiss trout and pike found with excessive PFAS levels
This content was published on
Trout and pike in the lakes of western Switzerland contain excessive levels of the chemical group PFAS. This could jeopardise their saleability.
Swiss unions call for shorter days for construction workers
This content was published on
Construction workers need shorter days, say Swiss trade unions. Demonstrations are planned in Zurich and Lausanne on May 17.
Rapeseed restrictions cause problems for Swiss farmers
This content was published on
More and more Swiss farmers are abandoning rapeseed cultivation because they lack the means to protect the sensitive plants from pests.
Tariffs: Swiss index SMI down sharply in pre-market trading
This content was published on
The trade war unleashed by US President Donald Trump is causing a sell-off. According to experts' calculations, the leading Swiss SMI index is likely to fall by around 2%.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.